Sun Pharmaceutical Industries Q1 Results

  • BSE: 524715
  • NSE: SUNPHARMA
  • ISIN: INE044A01036
  • Sector: Biotechnology & Drugs
BSE
1,864.9518.50 (1.00%)
Volume33.96 K
Updated: Thu 12 Sep, 2024 | 15:52:53
NSE
1,865.419.70 (1.07%)
Volume2.74 M
Updated: Thu 12 Sep, 2024 | 15:41:35
Today: 1,840.80
1,870.90
52-Wk: 1,069.00
1,857.95

Q1 Results Highlights

  • Total Income
    ₹12,652.75 Cr.
    (5.96%)
  • Operating Profit
    ₹3,002.94 Cr.
    (27.48%)
  • Profit After Tax
    ₹2,835.62 Cr.
    (40.20%)
  • Operating Margin
    23.73%
    (20.31%)
Note: Comparison is on YoY basis

Quarterly - Sun Pharmaceutical Industries Q1 Results

*All figures in crores except per share values
Fiscal PeriodJun 24Mar 23QoQ CompJun 23YoY Comp
Total Revenue 12,652.7510,930.675.59%11,940.845.96%
Selling/ General/ Admin Expenses Total 2,454.622,179.556.75%2,402.042.19%
Depreciation/ Amortization 655.13671.530.73%651.320.58%
Other Operating Expenses Total 3,864.633,671.60-8.24%3,450.9011.99%
Total Operating Expense 9,649.818,944.350.07%9,585.300.67%
Operating Income 3,002.941,986.3228.36%2,355.5427.48%
Net Income Before Taxes 3,423.502,239.6921.59%2,481.1437.98%
Net Income 2,835.621,984.476.82%2,022.5440.20%
Diluted Normalized EPS 11.808.962.59%9.4924.37%

Recommended For You

    More Recommendations

    Trending Stocks

      Subscribe to Our Newsletter

      Get daily newsletters around different themes from livemint.

      Subscribe
      HomeMarketsPremiumInstant LoanMint Shorts